SB 2007 requires pharmacy benefit managers (PBMs) in Oklahoma to pay administrative fees to pharmacies when they adjust reimbursement rates for the same drug within 30 days after a successful appeal. Specifically, if a PBM increases reimbursement based on an appeal but then lowers it again for the same drug within 30 days, the PBM must pay $100 immediately, escalating to $500 after 90 days or $1,000 after 180 days if unpaid. The bill directly affects pharmacies and PBMs by mandating these fee payments for disputed reimbursements, ensuring providers aren’t financially penalized for legitimate appeal outcomes. It also includes other provisions like weekly MAC price updates and requirements for PBMs to provide clear documentation during reimbursement disputes. The law takes effect November 1, 2026.
SB 1833 directs Oklahoma's Department of Human Services to seek a federal waiver preventing SNAP (food stamp) benefits from being used to purchase candy and soft drinks, and to potentially exclude other "nonnutritive" foods. The department must submit a waiver request to the USDA with public health justification, an implementation plan for retail point-of-sale systems, and an education strategy for recipients. If approved, the restrictions would take effect within six months, requiring annual reports to state leaders on SNAP spending patterns and program impacts. This bill directly affects SNAP recipients in Oklahoma by changing eligible purchases and requires federal approval for implementation.
SB 1344 creates Oklahoma's Insulin Access and Affordability Program, administered by the State Department of Health, to increase access to affordable insulin for residents. The bill requires the Department to provide financial support to a nonprofit pharmaceutical manufacturer developing fast-acting biosimilar insulin, contingent on the manufacturer matching funds and agreeing to produce insulin at low cost without rebates (except as required by law). The agreement includes annual reporting on development progress and repayment terms if the insulin isn't produced and distributed as promised. This program directly affects Oklahoma residents needing insulin, public and private payors, and the specified nonprofit manufacturer.
SB 1134 allocates $100,000 from Oklahoma's General Revenue Fund to the Oklahoma Health Care Authority for the 2026 fiscal year. The bill directly provides funding for the Authority to carry out its legal duties. It declares an emergency to allow immediate implementation upon passage. This is a procedural appropriations measure with no policy changes beyond the specified funding amount.
SB 1142 allocates $100,000 from unallocated state funds to Oklahoma's Department of Mental Health and Substance Abuse Services for the 2025-2026 fiscal year. The funding is intended to support the department's existing duties, including providing mental health and substance abuse services to Oklahomans. The bill declares an emergency to allow immediate implementation upon approval, bypassing standard legislative timelines. This is a procedural funding measure, not a policy change, and remains pending before the Appropriations Committee.
SB 1290 allocates $3 million from Oklahoma's General Revenue Fund to maintain the state's 2-1-1 hotline for the 2027 fiscal year. The funding ensures the hotline continues providing direct support for basic needs like food, shelter, clothing, transportation, and medical assistance. This appropriation directly affects Oklahomans who rely on the 2-1-1 service for immediate help. The bill takes effect July 1, 2026.
HB 3329 extends the expiration date of Oklahoma's Long-Term Care Facility Advisory Board from July 1, 2025, to July 1, 2027. The bill modifies Oklahoma Statutes Section 1-1923 to continue the board's operation, which advises the State Commissioner of Health on long-term care services. The advisory board, composed of 13 members including healthcare professionals, facility operators, and public representatives, provides recommendations on care standards for nursing homes, residential care facilities, and adult day care centers. The bill takes effect July 1, 2026, as an emergency measure.
SB 1369 allocates $5.7 million from Oklahoma's general state funds to sustain and expand the state's 9-8-8 suicide and crisis hotline operations for the 2026-2027 fiscal year. This funding directly supports Oklahomans in mental health crises by ensuring access to the 9-8-8 hotline service. The bill provides specific funding to maintain current operations while increasing capacity for crisis response. It becomes effective July 1, 2026, and declares an emergency due to the urgent need for mental health support.
HB 4457 prohibits pharmacy benefits managers (PBMs) from owning or controlling pharmacy licenses in Oklahoma. The State Board of Pharmacy must revoke licenses of violators after November 2026, though it may issue temporary licenses for rare, orphan, or limited-distribution drugs until September 2028. Pharmacies must notify patients of service changes by January 2027, and the Board must provide lists of compliant pharmacies. This law prevents conflicts of interest by restricting PBMs from owning pharmacies.
This bill proposes a constitutional amendment to establish the "Tobacco Settlement Endowment Trust Fund" for Oklahoma's tobacco settlement funds. It requires that at least 75% of new tobacco settlement payments (after 2001) be deposited into this trust fund, with specific percentages increasing over time. The trust fund's earnings must be used for cancer research, tobacco prevention programs, children's health initiatives, senior care programs, and education-related expenses, with unused funds remaining in the trust. The amendment creates two governing boards to manage investments and allocate funds, and it would require voter approval before taking effect.
